PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-13.58%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-21.95%
Negative gross profit growth while MAXN is at 73.39%. Joel Greenblatt would examine cost competitiveness or demand decline.
-32.27%
Negative EBIT growth while MAXN is at 71.83%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-195.63%
Negative operating income growth while MAXN is at 66.50%. Joel Greenblatt would press for urgent turnaround measures.
167.94%
Net income growth above 1.5x MAXN's 73.10%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
168.87%
EPS growth of 168.87% while MAXN is zero. Bruce Berkowitz would see if minimal gains can accelerate over time.
155.10%
Diluted EPS growth above 1.5x MAXN's 73.09%. David Dodd would see if there's a robust moat protecting these shareholder gains.
1.77%
Share change of 1.77% while MAXN is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
18.91%
Diluted share change of 18.91% while MAXN is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
-86.96%
Negative OCF growth while MAXN is at 93.92%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-82.83%
Negative FCF growth while MAXN is at 91.23%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
204.54%
Positive 10Y revenue/share CAGR while MAXN is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
-29.48%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-43.62%
Negative 3Y CAGR while MAXN stands at 7.06%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-246.13%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-122.15%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-319.20%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
113.47%
Positive 10Y CAGR while MAXN is negative. John Neff might see a substantial advantage in bottom-line trajectory.
174.47%
Positive 5Y CAGR while MAXN is negative. John Neff might view this as a strong mid-term relative advantage.
106.82%
Positive short-term CAGR while MAXN is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
-25.53%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
16.39%
Positive short-term equity growth while MAXN is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-21.43%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
2.59%
We show growth while MAXN is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
5.98%
Positive asset growth while MAXN is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
1.39%
Positive BV/share change while MAXN is negative. John Neff sees a clear edge over a competitor losing equity.
-4.55%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-2.87%
Our R&D shrinks while MAXN invests at 3.39%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
5.58%
We expand SG&A while MAXN cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.